Redhill biopharma ltd. (RDHL)
CashFlow / Yearly
Dec'17Dec'16Dec'15
OPERATING ACTIVITIES:
Comprehensive loss

-45,544

-29,370

-21,090

Adjustments in respect of income and expenses not involving cash flow:
Share-based compensation to employees and service providers

2,235

1,679

1,364

Depreciation

81

44

36

Write-off of intangible assets

845

-

100

Fair value adjustment on derivative financial instruments

5,687

1,152

888

Fair value losses on financial assets at fair value through profit or loss

-127

67

-

Revaluation of bank deposits

123

274

69

Issuance cost in respect of warrants

-

368

-

Exchange differences in respect of cash and cash equivalents

-367

-39

150

Total adjustments in respect of income and expenses not involving cash flow

-2,889

559

693

Changes in assets and liability items:
Increase in trade receivables

-1,429

99

-

Decrease (increase) in prepaid expenses and other receivables

-1,728

612

702

Increase in inventory

-653

-

-

Increase (decrease) in accounts payable

4,745

-60

153

Increase (decrease) in accrued expenses and other current liabilities

2,729

-98

1,716

Total changes in assets and liability items

-3,664

-553

-2,571

Net cash used in operating activities

-44,769

-28,258

-17,826

INVESTING ACTIVITIES:
Purchase of fixed assets

146

85

14

Purchase of intangible assets

1,035

35

1,620

Change in investment in current bank deposits

13,000

-36,838

29,500

Purchase of non-current bank deposits

-

-

58

Purchase of financial assets at fair value through profit or loss

21,923

12,246

-

Proceeds from sale of financial assets at fair value through profit or loss

17,522

-

-

Maturity of non-current bank deposits

-

-

10,000

Net cash provided by (used in) investing activities

-18,582

24,472

-21,192

FINANCING ACTIVITIES:
Proceeds from issuance of ordinary shares, net of expenses

22,216

35,754

54,684

Exercise of warrants and options into ordinary shares, net of expenses

3,437

263

108

Net cash provided by financing activities

25,653

36,017

54,792

DECREASE IN CASH AND CASH EQUIVALENTS

-37,698

32,231

15,774

EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS

367

39

-150

SUPPLEMENTARY INFORMATION ON INTEREST RECEIVED IN CASH

469

408

236

Supplementary information on investing activities not involving cash flows - Purchase of intangible assets.

-

-

1,925